The prices of our software depend on multiple factors.

Type of License: We offer different licensing options to suit various business needs, each with its own set of features and benefits. These include Annual Licenses, Pay-Per-Test, or Consulting Services.

Number of Endpoints: The cost is also influenced by the number of endpoints you wish to purchase. Endpoints vary by type of software.

We currently offer 2 types of licenses to best suit your company’s needs.

Annual License: CASE Ultra, QSAR Flex, and META Ultra have the option for an Annual License. We offer a one-year license for software products, which includes the cost of upgrades, maintenance, and technical support. The license is for use on a single machine, although we can offer a discount for additional machines. Also, the license allows the program to be installed on a server and used by several users via remote desktop.

Pay-Per-Test: At this time, we offer a Pay-Per-Test option in our CASE Ultra software. This allows you to purchase a specific number of queries upfront. Instead of committing to an annual renewal, you have the freedom to use these queries as needed. This model provides you with greater control over your usage and budget, ensuring you only pay for what you use. It’s an ideal solution for businesses that require scalability and prefer a usage-based pricing structure.

We also offer Consulting Services completed by one of our scientists. You have the option for a Result Only report or an Expert Review. This is best for minimal testing needs and does not require the installation of our software.

Please contact us by phone, email, or by submitting the request form and we’ll send you a list of approximate prices for our software and databases. If you reach a stage where you have decided to purchase our products, contact us again with a specific list of what you want to buy and we will send a detailed price quote.

The variations in our software are tailored to the specific tests you aim to conduct.

CASE Ultra: Gather reliable toxicity data and high-quality (Q)SAR predictions using OECD-validated CASE Ultra models. Add your data with a built-in QSAR building optional tool.

QSAR Flex: QSAR Flex was first created in collaboration with the US FDA to aid in evaluating the carcinogenic potency of N-nitrosamines. The software is designed to deploy models with continuous or categorical activities for non-binary outcomes and assessments, ideal for complex endpoints.

META Ultra: Identify Phase I and Phase II metabolites through a high-quality database of experimentally observed metabolic reactions. META will classify the site of metabolism (SOM) through (Q)SAR prediction to generate predicted metabolite structures.

Our training sets contain data from public and proprietary sources including the FDA, GENETOX, NTP, CCRIS, and IARC. We strive to update our databases on a regular schedule to provide users with the most up-to-date analyses.

Our software programs run on Microsoft Windows family of operating systems, Windows 8 or higher, and Windows Server 2016 and newer versions are all supported. 

Minimum system requirements are 64 bit machine, Windows 8 or higher with .NET 4.7.2 SP1, dual core processor, 120 GB hard drive, 4GB memory.

MultiCASE has a long-standing Research Collaboration Agreement (RCA) with the US FDA Center for Drug Evaluation and Research (CDER) and worked together to build various CASE Ultra Models for mutagenicity, carcinogenicity in rodents, developmental and reproduction, maximum tolerated dose, and adverse effects.

Typically, we aim to update our software on an annual basis.

We offer limited free trials on a case-by-case basis. If you’re interested in a free trial, please contact us for more information.